Skip to content

Whether Using Sequential pH Would Improve Human Blastocyst Formation

Sequential pH Effect on Blastocyst Formation Rate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03641014
Enrollment
1312
Registered
2018-08-21
Start date
2018-08-28
Completion date
2019-06-10
Last updated
2019-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Any drift in extracellular pH (pHe) from the intercellular pH (pHi) could alter the mechanism regulating transporters and exchangers through the plasma membrane. This could lead to difficulty in restoring the physiological level of pHi. The critical stages that lack robust mechanism of regulating the pHi are the denuded oocyte, early stage of fertilization or a thawed embryo. This, in turn, could lead to a significant effect of the perturbations on embryo development. Convincing evidence regarding the optimal pHe for culturing human embryo is, so far, scanty and mostly anecdotal. The embryo has been reported to have a compensatory mechanism to grow at pHe between 7.0-7.4. Others have recommended that embryo need a sequential pH to viably grow suggesting that the post-genomic activation stage needs a slightly alkaline range of pH. However, whether this holds true remains to be examined.

Interventions

OTHERpH Effect on blastocyst formation

to investigate which pH is suitable for each stage of embryo development

Sponsors

Banoon IVF Center
CollaboratorOTHER
Quena IVF Centre
CollaboratorUNKNOWN
Ibn Sina Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* ICSI cycles

Exclusion criteria

* No exclusion

Design outcomes

Primary

MeasureTime frameDescription
Ongoing Pregnancy rate12 weekswomen with continued pregnancy at week 12 of gestation

Secondary

MeasureTime frameDescription
rate of usable blastocysts6 days of culturenumber of blastocysts suitable for transfer on day 5 or 6
Blastocyst formation rate6 days of culturenumber of formed blastocyst per Fertilized oocyte
Clinical pregnancy rate3 monthsnumber of women with ultrasound detection of sacs with heartbeat per stimulated cycle
Implantation rate7 weeksnumber of sacs with a heartbeat

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026